email article
Anti-inflammatory oral drug colchicine improved COVID-19 outcomes for patients with relatively mild cases, according to certain topline results from the COLCORONA trial announced in a brief press release.
Overall, the drug used for gout and rheumatic diseases reduced risk of death or hospitalizations by 21% versus placebo, which approached statistical significance.
However, there was a significant effect among the 4,159 of 4,488 patients who had their diagnosis of COVID-19 confirmed by a positive PCR test:
25% fewer hospitalizations
44% fewer deaths
If upheld after peer review a full manuscript was posted two days later to the medRxiv preprint server colchicine could become the first oral drug proven to benefit non-hospitalized patients with COVID-19.
January 25, 2021
For patients successfully resuscitated after cardiac arrest, it’s possible to predict their odds of survival by counting how many risk factors are present, data from the International Cardiac Arrest Registry (INTCAR) confirm.
Thanks to more-aggressive care, such as targeted temperature management (TTM) and coronary angiography/intervention, survival to hospital discharge for these patients has risen from around 25% to 50% in recent years, researchers say. Still, the burden of “multiple unfavorable features,” as worded in a 2015 algorithm from the American College of Cardiology (ACC) Interventional Council, can portend worse outcomes even in the face of this advanced treatment.
Exactly how many risk factors mattered, and to what extent, hadn’t previously been pinpointed.
As of January 2021, in the United States we are now on month 10 of the COVID-19 pandemic. One year ago, we followed events unfolding in China. One of the first takeaways from the Chinese experience
The Long-term Cardiovascular Impact of COVID-19
Evidence suggests COVID long-haulers may have lingering cardiac impacts from their coronavirus infections
Cardiologists are taking a closer look at the possible long-term cardiovascular effects on COVID long-hauler patients who still show symptoms long after they should be recovered from the virus. Getty Images
With nearly a year of experience with the COVID-19 (SARS-CoV-2) virus, it has been found that some post-COVID patients experience long-term lingering coughs, cognitive issues and other complains months after they recover from the virus. These long-haulers are also appear to be having the heart issues as well. Determining the long-term impact of coronavirus will certainly be one of the top cardiology issues discussed in 2021.
Share January 23, 2021, 8:40 AM
The writer of twice-monthly health columns is a practicing cardiologist, clinical professor at Wayne State University School of Medicine and founder of the Kahn Center for Cardiac Longevity in Bingham Farms. He s an author who has appeared on Dr. Oz and The Doctors Show.
By Joel Kahn It shouldn t be surprising that what you eat matters greatly in terms of your health. It may matter the most when you are healing from an illness.
This Baconator Cheeseburger and Baconator Fries have 1,500 calories combined. (Photo: Wendy s) The ability of vitamin-rich and nutrient-rich fresh foods, abundant in colors and plant fiber, to promote recovery from medical issues, is proven. Many studies confirm that processed meats and other foods with excess saturated fats, salt and sugar, along with sugar-sweetened beverages, are all harmful to our health.